Identification of HIV vaccine candidate peptides by screening random phage epitope libraries - PubMed (original) (raw)
Identification of HIV vaccine candidate peptides by screening random phage epitope libraries
P M Keller et al. Virology. 1993 Apr.
Abstract
Most synthetic HIV-1 gp120 V3 loop peptides that are used as immunogens in experimental HIV-1 vaccine studies are modeled from the naturally occurring viral gp120 V3 loops. In experimental animals these immunogens generally elicit type (or variant)-specific neutralizing antibodies that are not broadly reactive among HIV-1 variants. In an attempt to find a more general structure for the V3 loop, we have obtained candidates that mimic V3 loop sequences by screening random epitopes displayed in a fusion phage 15-residue epitope library. Human monoclonal antibody 447-52D, a highly potent and broadly reactive virus-neutralizing antibody that recognizes the conserved V3 loop tip motif GPXR, was the probe. By using a screening method that was designed specifically for this work, we identified hundreds of reactive phage clones, 70 of which were sequenced. Over 98% of the epitopes contain the motif GPXR, yet none of the 70 are an identical match to any V3 variant loop described to date. One of these sequences was synthesized as the beta-maleimidopropionyl 15-mer peptide, covalently conjugated to a carrier and used to immunize rabbits. High anti-peptide titers were obtained in all animals with three of four individual responses also binding to a peptide that is representative of the "North American consensus" V3 loop. The sera from these three positive rabbits neutralized HIV-1 variant SF-2 in vitro. In addition, one of them was capable of neutralizing variant AL-1. Both of these variants are considered to have V3 loops of the North American consensus type. Thus, neutralizing responses were obtained by use of an immunogen that was selected for its ability to bind a broadly reactive human monoclonal antibody rather than modeled from an HIV-1 gp120 V3 loop sequence.
Similar articles
- Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.
Pan R, Qin Y, Banasik M, Lees W, Shepherd AJ, Cho MW, Kong XP. Pan R, et al. J Virol. 2018 Mar 14;92(7):e01894-17. doi: 10.1128/JVI.01894-17. Print 2018 Apr 1. J Virol. 2018. PMID: 29343576 Free PMC article. - Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R. Chakraborty K, et al. Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588. Biochem J. 2006. PMID: 16827663 Free PMC article. - The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1.
Zolla-Pazner S, Zhong P, Revesz K, Volsky B, Williams C, Nyambi P, Gorny MK. Zolla-Pazner S, et al. AIDS Res Hum Retroviruses. 2004 Nov;20(11):1254-8. doi: 10.1089/aid.2004.20.1254. AIDS Res Hum Retroviruses. 2004. PMID: 15588347 - Libraries of human rhinovirus-based HIV vaccines generated using random systematic mutagenesis.
Resnick DA, Smith AD, Zhang A, Geisler SC, Arnold E, Arnold GF. Resnick DA, et al. AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S47-52. AIDS Res Hum Retroviruses. 1994. PMID: 7865333 Review. - Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine.
Sirois S, Touaibia M, Chou KC, Roy R. Sirois S, et al. Curr Med Chem. 2007;14(30):3232-42. doi: 10.2174/092986707782793826. Curr Med Chem. 2007. PMID: 18220757 Review.
Cited by
- The development of inovirus-associated vector vaccines using phage-display technologies.
Stern Z, Stylianou DC, Kostrikis LG. Stern Z, et al. Expert Rev Vaccines. 2019 Sep;18(9):913-920. doi: 10.1080/14760584.2019.1651649. Epub 2019 Sep 8. Expert Rev Vaccines. 2019. PMID: 31373843 Free PMC article. Review. - HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW, Morrison O, Vassell R, Weiss CD. Keller PW, et al. J Virol. 2018 Jul 31;92(16):e00583-18. doi: 10.1128/JVI.00583-18. Print 2018 Aug 15. J Virol. 2018. PMID: 29875245 Free PMC article. - Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines.
Hassapis KA, Stylianou DC, Kostrikis LG. Hassapis KA, et al. Viruses. 2014 Dec 17;6(12):5047-76. doi: 10.3390/v6125047. Viruses. 2014. PMID: 25525909 Free PMC article. Review. - Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography.
Dutta M, Liu J, Roux KH, Taylor KA. Dutta M, et al. J Virol. 2014 Nov;88(21):12265-75. doi: 10.1128/JVI.01596-14. Epub 2014 Aug 13. J Virol. 2014. PMID: 25122783 Free PMC article. - Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design.
Kong L, Sattentau QJ. Kong L, et al. J AIDS Clin Res. 2012;S8:3. doi: 10.4172/2155-6113. Epub 2012 Mar 22. J AIDS Clin Res. 2012. PMID: 23227445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous